Case report: Invasive fungal infection in a patient with a rare CVID-causing gene (TNFRSF13B) mutation undergoing AML treatment
暂无分享,去创建一个
A. Godwin | A. Yacoub | Stephen Hyter | J. McGuirk | Kenneth P Byrd | Haitham Abdelhakim | Carine Tabak
[1] B. Powell,et al. Incidence of Breakthrough Fungal Infections in Acute Myeloid Leukemia Patients Receiving Low Intensity Therapy in the Upfront and Relapsed/Refractory Setting , 2021, Blood.
[2] A. Wei,et al. New Drugs Bringing New Challenges to AML: A Brief Review , 2021, Journal of personalized medicine.
[3] C. Kauffman,et al. Breakthrough Invasive Fungal Infections in Patients with Acute Myeloid Leukemia , 2020, Mycopathologia.
[4] A. Pession,et al. Clinical Associations of Biallelic and Monoallelic TNFRSF13B Variants in Italian Primary Antibody Deficiency Syndromes , 2016, Journal of immunology research.
[5] G. Lyman,et al. Primary antifungal prophylaxis during curative-intent therapy for acute myeloid leukemia. , 2015, Blood.
[6] S. Rosengren,et al. TNF receptor superfamily member 13b (TNFRSF13B) hemizygosity reveals transmembrane activator and CAML interactor haploinsufficiency at later stages of B-cell development. , 2015, The Journal of allergy and clinical immunology.
[7] Daniel J Weisdorf,et al. Acute Myeloid Leukemia. , 2015, The New England journal of medicine.
[8] E. Anaissie,et al. How we treat invasive fungal diseases in patients with acute leukemia: the importance of an individualized approach. , 2014, Blood.
[9] V. Bhatt,et al. Invasive fungal infections in acute leukemia , 2011, Therapeutic advances in hematology.
[10] D. DeAngelo,et al. Invasive fungal disease in patients treated for newly diagnosed acute leukemia , 2010, American journal of hematology.
[11] M. van der Burg,et al. TACI mutations and disease susceptibility in patients with common variable immunodeficiency , 2009, Clinical and experimental immunology.
[12] H. Einsele,et al. Significant alterations in the epidemiology and treatment outcome of invasive fungal infections in patients with hematological malignancies , 2008, International journal of hematology.
[13] J. Perfect,et al. Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia. , 2007, The New England journal of medicine.
[14] L. Pagano,et al. Design and Methods , 2022 .
[15] A. Schäffer,et al. Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans , 2005, Nature Genetics.
[16] S. Teutsch,et al. Excess Mortality, Hospital Stay, and Cost Due to Candidemia: A Case-Control Study Using Data From Population-Based Candidemia Surveillance , 2005, Infection Control & Hospital Epidemiology.
[17] R. Geha,et al. TACI and BAFF-R mediate isotype switching in B cells , 2005, The Journal of experimental medicine.
[18] Nina Singh,et al. Trends in the epidemiology of opportunistic fungal infections: predisposing factors and the impact of antimicrobial use practices. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[19] Paul A. Moore,et al. Tumor Necrosis Factor (TNF) Receptor Superfamily Member TACI Is a High Affinity Receptor for TNF Family Members APRIL and BLyS* , 2000, The Journal of Biological Chemistry.